NASDAQ · Medical - Devices
TNON (TNON) Stock
$0.18
-3.00%
NASDAQ: TNON
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Tenon Medical Regains Nasdaq Compliance on Equity Requirement
MT Newswires · Jul 20, 2026
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement
ACCESS Newswire · Jul 20, 2026
Tenon Medical's Catamaran SI Joint Fusion System Gets FDA 510(k) Clearance; Shares Rise Pre-Bell
MT Newswires · Jul 2, 2026
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System
ACCESS Newswire · Jul 2, 2026
WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering
PR Newswire · Jul 1, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held10.25%
Institutions Held2.12%
Institutions Float Held2.36%
Peer Comparison
About TNON
TNON is led by CEO Steven Foster, employs 27 people, headquartered in US, publicly traded since 2022.
TNON stock trades at $0.18 with a market capitalization of $1.36M. The stock is valued at a price-to-earnings (P/E) ratio of -0.42, price-to-book of 1.04, price-to-sales of 1.13. Over the past 52 weeks the stock has ranged between $0.18 and $2.48, and currently trades 92.7% below its 52-week high.
On profitability, TNON generates a return on equity (ROE) of -260.00%, return on capital employed of -260.00%, an operating margin of -325.00%, a net profit margin of -2.68%.